No shortcuts to SARS-CoV-2 antivirals

Science. 2021 Jul 30;373(6554):488-489. doi: 10.1126/science.abj9488.

Authors

Aled Edwards^{1

2}, Ingo V Hartung^{1

2}

Affiliations

¹ Structural Genomics Consortium, 101 College Street, Toronto, Canada. aled.edwards@utoronto.ca ingo.hartung@merckgroup.com.
² Merck Healthcare KGaA, Frankfurter Straße 250, Darmstadt, Germany. aled.edwards@utoronto.ca ingo.hartung@merckgroup.com.

PMID: 34326222
DOI: 10.1126/science.abj9488

No abstract available

Publication types

Comment

MeSH terms

Antiviral Agents* / pharmacology
Antiviral Agents* / therapeutic use
COVID-19*
Humans
SARS-CoV-2
Virus Replication / drug effects

Substances

Antiviral Agents